A brand new survey from the Alzheimer’s Affiliation finds that folks need to know if they’re within the early phases of the illness, and are open to drug therapy.
MARY LOUISE KELLY, HOST:
Older People say they need to know if they’re within the early phases of Alzheimer’s, and they might fortunately take a blood take a look at to seek out out. That is in keeping with a brand new nationwide survey by the Alzheimer’s Affiliation. NPR’s Jon Hamilton stories the outcomes present how attitudes towards the illness are altering.
JON HAMILTON, BYLINE: Traditionally, individuals experiencing issues with reminiscence and pondering have been hesitant to study the trigger. Elizabeth Edgerly is a medical psychologist who directs group applications for the Alzheimer’s Affiliation.
ELIZABETH EDGERLY: Folks would usually say, effectively, gosh, I would not need to know, or why would I need to know?
HAMILTON: However Edgerly says the affiliation’s survey of 1,700 People 45 and older reveals that is not the case.
EDGERLY: Seventy-nine % stated that they wish to know if they’d Alzheimer’s earlier than the signs seem or at the least earlier than the signs have an effect on their every day actions.
HAMILTON: One purpose could also be that it is now simpler to seek out out. Only a few years in the past, it took a PET scan or spinal faucet to verify the presence of sticky amyloid plaques within the mind. Now a easy blood take a look at can present the reply. Edgerly says survey respondents had been passionate about this strategy.
EDGERLY: 9 out of 10 individuals stated, yeah, I might take a blood take a look at, and particularly if I do know that if I’ve Alzheimer’s, there’s one thing I can do about it.
HAMILTON: Like drug therapy. Most respondents stated they might take a medicine to decelerate the illness, even when it had dangers. There are actually two medication like that in the marketplace, and Edgerly says that provides individuals one more reason to get a analysis whereas they’re nonetheless able to making their very own selections.
EDGERLY: Now, individuals can communicate for themselves. They’ll articulate what they’d like for his or her future. They’ll resolve whether or not they need to attempt remedies. It is actually a really completely different state of affairs.
HAMILTON: Alzheimer’s stays a formidable illness, however Dr. Nathaniel Chin, a geriatrician on the College of Wisconsin, says individuals dwelling with Alzheimer’s illness are extra optimistic now that drug therapy is feasible.
NATHANIEL CHIN: Even when it does not cease the illness in its tracks, I believe it tells people who we’re making progress, and so they need to know in the event that they doubtlessly may have this remedy or possibly the following remedy or two therapies down the highway.
HAMILTON: Chin says the survey outcomes are in keeping with what he is seeing in his personal observe.
CHIN: I do not suppose persons are as fearful as they’ve been previously. I believe there is a need to simply know what’s taking place to our our bodies.
HAMILTON: Chin says many docs, although, are nonetheless skeptical about drug therapy, which affords solely a modest profit. Consequently, he says, many are nonetheless reluctant to induce their sufferers to get examined.
CHIN: Some sufferers are forward of their docs on this regard. They’re fascinated about this. They need this data, and they will ask about it.
HAMILTON: Chin says he does supply blood assessments to sufferers with cognitive issues, and he expects the assessments to grow to be more and more widespread. However that is prone to convey some new challenges. For instance, many well being professionals usually are not educated to counsel individuals who have simply realized they’ve Alzheimer’s. And Chin says a constructive take a look at end in somebody’s medical document has the potential to jeopardize their job or medical insurance.
CHIN: There are protections for individuals who study their genetic data, however as of now, there usually are not protections for people who find themselves studying if you’re cognitively unimpaired or cognitively wholesome.
HAMILTON: Chin says now that extra persons are discovering out, it is as much as teams, together with the Alzheimer’s Affiliation, to push for these protections.
Jon Hamilton, NPR Information.
Copyright © 2025 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional data.
Accuracy and availability of NPR transcripts might differ. Transcript textual content could also be revised to appropriate errors or match updates to audio. Audio on npr.org could also be edited after its unique broadcast or publication. The authoritative document of NPR’s programming is the audio document.
